|

AUD/USD seesaws above 2021 low after upbeat Australia Q3 GDP

  • AUD/USD holds onto the choppy trading range following Aussie GDP data.
  • Australia Q3 GDP came in better than expected on both QoQ and YoY.
  • Market sentiment dwindles amid Omicron concerns, fears of faster Fed tapering.
  • US ISM PMI, ADP Employment Change and Powell’s testimony 2.0 will decorate calendar, virus updates are crucial

AUD/USD eases to 0.7120, after an initial uptick to 0.7132 on better-than-forecast Australia Q3 GDP details during Wednesday’s Asian session. That said, the quote remains inside a small range after bouncing off the yearly low before a few hours.

Australia’s third-quarter (Q3) GDP rose past 3.0% YoY expectations to 3.9% while the QoQ figures contracted than the -2.7% market consensus to -1.9%. Earlier in the day, Australia’s Commonwealth Bank Manufacturing PMI jumped past 58.2 figure to 59.2 for November.

Read: Aussie GDP arrives and pushes AUD/USD up a notch

Ahead of the data, Goldman Sachs’ Andrew Boak said, “Australia is well positioned for recovery into the year-end and 2022.” Also positive for the quote were comments from China’s Vice Premier Liu He who expects strong 2021 GDP for the dragon nation.

Even so, the quote remains at the mercy of the risk catalysts amid mixed concerns over the South African strain for the coronavirus, dubbed as Omicron. Also challenging the risk barometer pair are the reflation fears and Fed rate hike woes emanating from comments from Federal Reserve (Fed) Chairman Jerome Powell could be termed as the key catalysts.

In his testimony on the CARES act before the Senate Banking Committee, Fed’s Powell suggested the risk of more persistent inflation and signaled favor for discussing faster taper in the December meeting.

On the other hand, Moderna’s Chief Stéphane Bancel weighed on the risk appetite earlier in Tuesday by citing, per the Financial Times (FT), the risk of less effectiveness of the existing vaccines to tackle Omicron and months before pharmaceutical companies can manufacture new variant-specific jabs at scale. However, representatives of Pfizer and Oxford tried placating market fears citing no such evidence supporting the fact that the current jab will not be able to contain the virus strain.

Talking about data, the US CB Consumer Confidence dropped to a nine-month low and housing numbers also came in softer, which in turn joins recently positive data from Australia to offer an intermediate relief to the AUD/USD.

Other than the data, the bounce in the US Treasury yields from a two-month low and mildly positive stock futures also underpin the pair’s recovery moves.

Moving on, covid updates and the Fedspeak will be more important for AUD/USD traders while US ISM PMI and ADP Employment Change, as well as China Caixin Manufacturing PMI, will also offer additional details to watch for clear direction.

Technical analysis

AUD/USD holds onto corrective pullback from yearly low inside one-month-old bearish trend channel, staying below an ascending trend line established since November 2020.

Although oversold RSI conditions triggered the much-awaited bounce, bearish MACD signals and downward sloping channel keeps sellers hopeful to revisit the yearly low near 0.7062. That said, the 0.7210 hurdle, including the stated channel’s upper line and 78.6% Fibonacci retracement (Fibo.) of November 2020 to February 2021 upside, acts as the near-term key hurdle. It’s worth noting that the 11-month-old support-turned-resistance line around 0.7145 guards the quote’s immediate upside.

Additional important levels

Overview
Today last price0.7132
Today Daily Change0.0004
Today Daily Change %0.06%
Today daily open0.7128
 
Trends
Daily SMA200.7283
Daily SMA500.7337
Daily SMA1000.7337
Daily SMA2000.7511
 
Levels
Previous Daily High0.7171
Previous Daily Low0.7063
Previous Weekly High0.7273
Previous Weekly Low0.7111
Previous Monthly High0.7537
Previous Monthly Low0.7063
Daily Fibonacci 38.2%0.7104
Daily Fibonacci 61.8%0.713
Daily Pivot Point S10.707
Daily Pivot Point S20.7012
Daily Pivot Point S30.6961
Daily Pivot Point R10.7178
Daily Pivot Point R20.7229
Daily Pivot Point R30.7287

Author

Anil Panchal

Anil Panchal

FXStreet

Anil Panchal has nearly 15 years of experience in tracking financial markets. With a keen interest in macroeconomics, Anil aptly tracks global news/updates and stays well-informed about the global financial moves and their implications.

More from Anil Panchal
Share:

Editor's Picks

EUR/USD eases marginally, back to 1.1800

EUR/USD navigates a narrow range on Thursday, hovering around the 1.1800 neighbourhood in a context of humble gains in the US Dollar. The pair’s lacklustre performance come amid the unabated trade uncertainty, geopolitical tensions in the Middle East and the cautious tone from the ECB’s Lagarde.

GBP/USD retreats from tops, approaching 1.3540

GBP/USD partially sets aside Wednesday’s strong advance and recedes to the 1.3540 region on Thursday. Cable’s modest retracement follows the equally acceptable gains in the Greenback, while investors continue to pencil in a potential BoE rate cut in March.

Gold clings to gains just below $5,200, focus on geopolitics

Gold is edging modestly higher on Thursday, adding to Wednesday’s uptick and holding just below the $5,200 mark per troy ounce against the backdrop of modest gains in the US Dollar. In the meantime, attention is turning to the geopolitical scenario following US-Iran nuclear talks.

Stellar: Relief bounce fades as bearish undertone persists

Stellar is trading around $0.16 at the time of writing on Thursday after rebounding more than 8% in the previous day. Derivatives data paints a negative picture as XLM’s short bets hit a monthly high while Open Interest continues to decline.

The one thing everyone is on the lookout for is US action of some sort against Iran

The FX market is minestrone soup these days. It is befuddled by conflicting data, rumors and small stories exaggerated out of proportion, and Trump-generated uncertainty. 

Bitcoin steadies as traders eye US–Iran talks

Bitcoin (BTC) price is stabilizing around $68,000 at the time of writing on Thursday after a 6.2% relief rally the previous day amid a broader downward trend.